Banner - NPPA Connect

Opinion|Videos|December 5, 2024

Treatment Switches and the Future of Hidradenitis Suppurativa Management

Author(s)Jennifer Hsiao, MD, Rani Cooper, MD

Panelists discuss how identifying optimal timing for treatment switches and emerging therapeutic innovations are reshaping the management landscape for hidradenitis suppurativa, with the potential to improve long-term patient outcomes.

Episodes in this series

3 experts in this video

EP. 1 Burden of Hidradenitis Suppurativa on Patients and Diagnostic Challenges

3 experts in this video

EP. 2 Efficacy and Safety of Current Treatments for HS

3 experts in this video

EP. 3 Future Innovations for HS Diagnosis and Management

3 experts in this video

EP. 4 Dosing Considerations and Assessing the Efficacy of Treatment

3 experts in this video

EP. 5 Potential Role of AI in HS Diagnosis

2 experts in this video

EP. 6 Early Recognition and Use of Biologics to Manage Hidradenitis Suppurativa

2 experts in this video

EP. 7 Setting Patient Expectations and Use of Combination Treatment for Hidradenitis Suppurativa

2 experts in this video

EP. 8 Treatment Switches and the Future of Hidradenitis Suppurativa Management

EP. 9 Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 1

EP. 9 Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 1

EP. 10 Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 2

EP. 10 Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 2

EP. 11 Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 3

EP. 11 Advancing Hidradenitis Suppurativa Care - Early Diagnosis, Biologic Therapies, and Multidisciplinary Approaches: Part 3

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

1 expert is featured in this series

Skin Clearance and PsA Prevention with Biologics in Psoriasis

ByBruce Strober, MD, PhD

September 1st 2026

1 expert is featured in this series

Case 3: Redefining How We Classify Psoriasis Severity

ByTina Bhutani-Jacques, MD

August 28th 2026

1 expert is featured in this series

Why One Foam Works for Scalp and Body Psoriasis

ByTina Bhutani-Jacques, MD

August 28th 2026

1 expert is featured in this series

Reading the Risankizumab Claims Data: Protopathic Bias and Study Limitations

ByBruce Strober, MD, PhD

August 25th 2026

1 expert is featured in this series

Case 2: Simplifying Therapy for Scalp and Body Psoriasis

ByTina Bhutani-Jacques, MD

August 21st 2026

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline

10 Skin Cancer Exam Tips

Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria

The Evolving CSU Pipeline: Biologics, BTK Inhibitors, and Biomarker-Guided Care

Journal Digest: September 2, 2026